 Rapid Influenza Diagnostic Testing Ridt Market Insights, Competitive Landscape, and Market Forecast - 2033
The global Rapid Influenza Diagnostic Testing RIDT Market is valued at US$ 1.5 Bn in 2026 and is projected to reach US$ 2 Bn by 2033, growing at a CAGR of 4.90% during the forecast period. Rapid in... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global Rapid Influenza Diagnostic Testing RIDT Market is valued at US$ 1.5 Bn in 2026 and is projected to reach US$ 2 Bn by 2033, growing at a CAGR of 4.90% during the forecast period. Rapid influenza diagnostic testing continues to gain importance as healthcare systems prioritize faster clinical decisions, early antiviral treatment, and timely infection control. RIDTs support point-of-care screening by detecting influenza viral antigens or related markers in respiratory samples, helping clinicians distinguish influenza from other respiratory illnesses during seasonal outbreaks. As patient volumes rise across hospitals, clinics, and diagnostic laboratories, demand is increasing for accurate, easy-to-use, and digitally enabled testing formats.Market Insights The market is being shaped by the need for quick turnaround times, improved test sensitivity, and broader access to respiratory disease diagnostics. Conventional RIDTs remain widely used because they are simple, affordable, and suitable for decentralized settings. However, digital RIDTs are gaining traction as providers seek automated result interpretation, better workflow efficiency, and reduced subjectivity. Influenza A+B combination tests are also becoming increasingly relevant because they allow simultaneous detection of major influenza strains, supporting faster treatment planning and public health monitoring. Technology development is another key market factor. Immunochromatographic and lateral flow assays continue to dominate routine rapid testing due to their portability and ease of deployment. At the same time, molecular diagnostics, including PCR and NAAT platforms, are expanding in settings where higher sensitivity is required. Immunofluorescence assays are also being adopted by laboratories seeking improved analytical performance. These developments are helping the RIDT market move from basic rapid screening toward more integrated, reliable, and data-supported diagnostic solutions. Drivers The primary driver for the Rapid Influenza Diagnostic Testing RIDT Market is the rising need for early diagnosis during influenza seasons and respiratory infection surges. Rapid detection helps physicians initiate antiviral therapy within the most effective treatment window, reduce unnecessary antibiotic use, and make informed decisions about patient isolation. Growing awareness of influenza complications among children, elderly patients, pregnant women, and immunocompromised populations is further increasing testing demand. Another major driver is the expansion of point-of-care diagnostics. Hospitals and clinics are adopting rapid testing solutions to reduce dependence on centralized laboratory turnaround times. Diagnostic laboratories are also upgrading their influenza testing menus to support seasonal surveillance and outbreak response. In addition, the experience of recent respiratory disease outbreaks has strengthened investment in rapid, scalable, and easy-to-administer diagnostic platforms. Manufacturers are responding with improved assay designs, digital readers, multiplex capabilities, and products that can fit into busy clinical workflows. Business Opportunity Business opportunities are emerging across product innovation, distribution expansion, and integrated respiratory testing. Companies that improve sensitivity while maintaining speed and affordability can strengthen adoption in clinics, emergency departments, and community healthcare settings. Digital RIDTs offer additional opportunity by enabling clearer results, connectivity, quality control, and data capture for healthcare networks. Suppliers can also benefit from developing compact platforms that support influenza A, influenza B, and combination testing with minimal training requirements. There is also growing opportunity in emerging healthcare markets where access to rapid diagnostics is expanding. Partnerships with hospitals, public health agencies, pharmacies, and diagnostic service providers can improve test availability during peak influenza seasons. Companies that offer reliable supply chains, training support, and flexible test formats are well positioned to serve both routine seasonal demand and outbreak-related spikes. As healthcare providers increasingly value rapid respiratory triage, RIDT manufacturers can expand through product differentiation, regulatory approvals, and region-specific commercialization strategies. Region Analysis North America remains a prominent market due to strong diagnostic infrastructure, high awareness of seasonal influenza, established reimbursement pathways, and widespread use of point-of-care testing in hospitals, clinics, and laboratories. The region also benefits from continuous product innovation and active participation by leading diagnostic companies. Europe shows steady demand supported by public health surveillance, clinical testing guidelines, and adoption of rapid testing across primary care and hospital settings. Asia Pacific is expected to present significant growth opportunities as healthcare access improves, respiratory disease testing expands, and governments strengthen infectious disease preparedness. Large patient populations, rising healthcare spending, and growing adoption of rapid diagnostics in countries across the region support market expansion. Latin America and the Middle East & Africa are also witnessing gradual uptake as diagnostic networks develop and healthcare providers seek faster tools for influenza screening. Across regions, demand is influenced by seasonal outbreak intensity, public health readiness, and availability of affordable rapid testing products. Overall, market participants are focusing on dependable rapid testing that balances clinical confidence with operational simplicity. As influenza continues to create seasonal pressure on healthcare systems, RIDTs will remain important for triage, surveillance, and treatment decisions, especially where fast results can improve patient flow and reduce diagnostic uncertainty across care settings worldwide. Key Players Leading companies in the Rapid Influenza Diagnostic Testing RIDT Market include: • Abbott Laboratories • F. Hoffmann-La Roche Ltd. (Roche Diagnostics) • Thermo Fisher Scientific Inc. • QuidelOrtho Corporation (Quidel Corporation) • Becton, Dickinson and Company (BD) • DiaSorin S.p.A. • Meridian Bioscience, Inc. • Sekisui Diagnostics • Hologic, Inc. • Bio-Rad Laboratories, Inc. • Siemens Healthineers AG • Luminex Corporation (now part of DiaSorin) • Analytik Jena AG (Endress+Hauser Group) • Princeton BioMeditech Corporation • Coris BioConcept Segmentation By Product Type • Conventional RIDTs • Digital RIDTs By Test Type • Influenza A Tests • Influenza B Tests • Influenza A+B Combination Tests By Technology • Immunochromatographic Assays • Lateral Flow Assays • Molecular Diagnostics (PCR & NAAT) • Immunofluorescence Assays By End User • Hospitals • Diagnostic Laboratories • Clinics • Research Institutes By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa Table of Contents1. Executive Summary1.1. Global Rapid Influenza Diagnostic Testing Ridt Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2026 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. COVID-19 Impact Analysis 2.5. Porter's Five Forces Analysis 2.6. Impact of Russia-Ukraine Conflict 2.7. PESTLE Analysis 2.8. Regulatory Analysis 2.9. Price Trend Analysis 2.9.1. Current Prices and Future Projections, 2025-2033 2.9.2. Price Impact Factors 3. Global Rapid Influenza Diagnostic Testing Ridt Market Outlook, 2020 - 2033 3.1. Global Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 3.1.1. Conventional RIDTs 3.1.2. Digital RIDTs 3.2. Global Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, Value (US$ Bn), 2020-2033 3.2.1. Influenza A Tests 3.2.2. Influenza B Tests 3.2.3. Influenza A+B Combination Tests 3.3. Global Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, Value (US$ Bn), 2020-2033 3.3.1. Immunochromatographic Assays 3.3.2. Lateral Flow Assays 3.3.3. Molecular Diagnostics (PCR & NAAT) 3.3.4. Immunofluorescence Assays 3.4. Global Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, Value (US$ Bn), 2020-2033 3.4.1. Hospitals 3.4.2. Diagnostic Laboratories 3.4.3. Clinics 3.4.4. Research Institutes 3.5. Global Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Region, Value (US$ Bn), 2020-2033 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Latin America 3.5.5. Middle East & Africa 4. North America Rapid Influenza Diagnostic Testing Ridt Market Outlook, 2020 - 2033 4.1. North America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 4.1.1. Conventional RIDTs 4.1.2. Digital RIDTs 4.2. North America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, Value (US$ Bn), 2020-2033 4.2.1. Influenza A Tests 4.2.2. Influenza B Tests 4.2.3. Influenza A+B Combination Tests 4.3. North America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, Value (US$ Bn), 2020-2033 4.3.1. Immunochromatographic Assays 4.3.2. Lateral Flow Assays 4.3.3. Molecular Diagnostics (PCR & NAAT) 4.3.4. Immunofluorescence Assays 4.4. North America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, Value (US$ Bn), 2020-2033 4.4.1. Hospitals 4.4.2. Diagnostic Laboratories 4.4.3. Clinics 4.4.4. Research Institutes 4.5. North America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Country, Value (US$ Bn), 2020-2033 4.5.1. U.S. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 4.5.2. U.S. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 4.5.3. U.S. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 4.5.4. U.S. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 4.5.5. Canada Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 4.5.6. Canada Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 4.5.7. Canada Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 4.5.8. Canada Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 4.6. BPS Analysis/Market Attractiveness Analysis 5. Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, 2020 - 2033 5.1. Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 5.1.1. Conventional RIDTs 5.1.2. Digital RIDTs 5.2. Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, Value (US$ Bn), 2020-2033 5.2.1. Influenza A Tests 5.2.2. Influenza B Tests 5.2.3. Influenza A+B Combination Tests 5.3. Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, Value (US$ Bn), 2020-2033 5.3.1. Immunochromatographic Assays 5.3.2. Lateral Flow Assays 5.3.3. Molecular Diagnostics (PCR & NAAT) 5.3.4. Immunofluorescence Assays 5.4. Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, Value (US$ Bn), 2020-2033 5.4.1. Hospitals 5.4.2. Diagnostic Laboratories 5.4.3. Clinics 5.4.4. Research Institutes 5.5. Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Country, Value (US$ Bn), 2020-2033 5.5.1. Germany Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.2. Germany Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.3. Germany Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.4. Germany Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.5.5. Italy Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.6. Italy Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.7. Italy Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.8. Italy Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.5.9. France Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.10. France Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.11. France Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.12. France Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.5.13. U.K. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.14. U.K. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.15. U.K. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.16. U.K. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.5.17. Spain Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.18. Spain Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.19. Spain Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.20. Spain Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.5.21. Russia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.22. Russia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.23. Russia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.24. Russia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.5.25. Rest of Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.26. Rest of Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.27. Rest of Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.28. Rest of Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.6. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Rapid Influenza Diagnostic Testing Ridt Market Outlook, 2020 - 2033 6.1. Asia Pacific Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 6.1.1. Conventional RIDTs 6.1.2. Digital RIDTs 6.2. Asia Pacific Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, Value (US$ Bn), 2020-2033 6.2.1. Influenza A Tests 6.2.2. Influenza B Tests 6.2.3. Influenza A+B Combination Tests 6.3. Asia Pacific Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, Value (US$ Bn), 2020-2033 6.3.1. Immunochromatographic Assays 6.3.2. Lateral Flow Assays 6.3.3. Molecular Diagnostics (PCR & NAAT) 6.3.4. Immunofluorescence Assays 6.4. Asia Pacific Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, Value (US$ Bn), 2020-2033 6.4.1. Hospitals 6.4.2. Diagnostic Laboratories 6.4.3. Clinics 6.4.4. Research Institutes 6.5. Asia Pacific Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Country, Value (US$ Bn), 2020-2033 6.5.1. China Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 6.5.2. China Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 6.5.3. China Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 6.5.4. China Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 6.5.5. Japan Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 6.5.6. Japan Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 6.5.7. Japan Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 6.5.8. Japan Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 6.5.9. South Korea Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 6.5.10. South Korea Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 6.5.11. South Korea Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 6.5.12. South Korea Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 6.5.13. India Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 6.5.14. India Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 6.5.15. India Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 6.5.16. India Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 6.5.17. Southeast Asia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 6.5.18. Southeast Asia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 6.5.19. Southeast Asia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 6.5.20. Southeast Asia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 6.5.21. Rest of SAO Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 6.5.22. Rest of SAO Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 6.5.23. Rest of SAO Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 6.5.24. Rest of SAO Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 6.6. BPS Analysis/Market Attractiveness Analysis 7. Latin America Rapid Influenza Diagnostic Testing Ridt Market Outlook, 2020 - 2033 7.1. Latin America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 7.1.1. Conventional RIDTs 7.1.2. Digital RIDTs 7.2. Latin America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, Value (US$ Bn), 2020-2033 7.2.1. Influenza A Tests 7.2.2. Influenza B Tests 7.2.3. Influenza A+B Combination Tests 7.3. Latin America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, Value (US$ Bn), 2020-2033 7.3.1. Immunochromatographic Assays 7.3.2. Lateral Flow Assays 7.3.3. Molecular Diagnostics (PCR & NAAT) 7.3.4. Immunofluorescence Assays 7.4. Latin America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, Value (US$ Bn), 2020-2033 7.4.1. Hospitals 7.4.2. Diagnostic Laboratories 7.4.3. Clinics 7.4.4. Research Institutes 7.5. Latin America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Country, Value (US$ Bn), 2020-2033 7.5.1. Brazil Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 7.5.2. Brazil Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 7.5.3. Brazil Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 7.5.4. Brazil Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 7.5.5. Mexico Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 7.5.6. Mexico Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 7.5.7. Mexico Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 7.5.8. Mexico Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 7.5.9. Argentina Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 7.5.10. Argentina Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 7.5.11. Argentina Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 7.5.12. Argentina Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 7.5.13. Rest of LATAM Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 7.5.14. Rest of LATAM Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 7.5.15. Rest of LATAM Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 7.5.16. Rest of LATAM Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 7.6. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, 2020 - 2033 8.1. Middle East & Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 8.1.1. Conventional RIDTs 8.1.2. Digital RIDTs 8.2. Middle East & Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, Value (US$ Bn), 2020-2033 8.2.1. Influenza A Tests 8.2.2. Influenza B Tests 8.2.3. Influenza A+B Combination Tests 8.3. Middle East & Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, Value (US$ Bn), 2020-2033 8.3.1. Immunochromatographic Assays 8.3.2. Lateral Flow Assays 8.3.3. Molecular Diagnostics (PCR & NAAT) 8.3.4. Immunofluorescence Assays 8.4. Middle East & Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, Value (US$ Bn), 2020-2033 8.4.1. Hospitals 8.4.2. Diagnostic Laboratories 8.4.3. Clinics 8.4.4. Research Institutes 8.5. Middle East & Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Country, Value (US$ Bn), 2020-2033 8.5.1. GCC Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 8.5.2. GCC Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 8.5.3. GCC Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 8.5.4. GCC Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 8.5.5. South Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 8.5.6. South Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 8.5.7. South Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 8.5.8. South Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 8.5.9. Egypt Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 8.5.10. Egypt Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 8.5.11. Egypt Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 8.5.12. Egypt Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 8.5.13. Nigeria Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 8.5.14. Nigeria Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 8.5.15. Nigeria Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 8.5.16. Nigeria Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 8.5.17. Rest of Middle East Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 8.5.18. Rest of Middle East Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 8.5.19. Rest of Middle East Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 8.5.20. Rest of Middle East Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 8.6. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Vs Segment Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. Abbott Laboratories 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Developments 9.4.2. F. Hoffmann-La Roche Ltd. (Roche Diagnostics) 9.4.3. Thermo Fisher Scientific Inc. 9.4.4. QuidelOrtho Corporation (Quidel Corporation) 9.4.5. Becton, Dickinson and Company (BD) 9.4.6. DiaSorin S.p.A. 9.4.7. Meridian Bioscience, Inc. 9.4.8. Sekisui Diagnostics 9.4.9. Hologic, Inc. 9.4.10. Bio-Rad Laboratories, Inc. 9.4.11. Siemens Healthineers AG 9.4.12. Luminex Corporation (now part of DiaSorin) 9.4.13. Analytik Jena AG (Endress+Hauser Group) 9.4.14. Princeton BioMeditech Corporation 9.4.15. Coris BioConcept 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
Fairfield Market Research社の 医療機器分野 での最新刊レポート
本レポートと同じKEY WORD（diagnostic）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
